BRPI0819055A2 - "uso de 3-(2,2,2-trimetilhidrazina) propionato e seus sais" - Google Patents

"uso de 3-(2,2,2-trimetilhidrazina) propionato e seus sais"

Info

Publication number
BRPI0819055A2
BRPI0819055A2 BRPI0819055A BRPI0819055A2 BR PI0819055 A2 BRPI0819055 A2 BR PI0819055A2 BR PI0819055 A BRPI0819055 A BR PI0819055A BR PI0819055 A2 BRPI0819055 A2 BR PI0819055A2
Authority
BR
Brazil
Prior art keywords
trimethylhydrazine
propionate
salts
Prior art date
Application number
Other languages
English (en)
Inventor
Ivars Kalvins
Ilmars Stonans
Original Assignee
Grindeks Jsc
Ilmars Stonans
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40364183&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0819055(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Grindeks Jsc, Ilmars Stonans filed Critical Grindeks Jsc
Publication of BRPI0819055A2 publication Critical patent/BRPI0819055A2/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BRPI0819055 2007-12-05 2008-12-03 "uso de 3-(2,2,2-trimetilhidrazina) propionato e seus sais" BRPI0819055A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07122359 2007-12-05
EP07122360 2007-12-05
PCT/EP2008/066712 WO2009071586A2 (en) 2007-12-05 2008-12-03 3-(2,2,2-trimethylhydrazinium) propionate salts for treating ischemic heart disease

Publications (1)

Publication Number Publication Date
BRPI0819055A2 true BRPI0819055A2 (pt) 2015-05-05

Family

ID=40364183

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0819055 BRPI0819055A2 (pt) 2007-12-05 2008-12-03 "uso de 3-(2,2,2-trimetilhidrazina) propionato e seus sais"

Country Status (36)

Country Link
US (1) US20110028438A1 (pt)
EP (1) EP2222376B1 (pt)
JP (1) JP2011506285A (pt)
KR (1) KR20100084687A (pt)
CN (1) CN101951991A (pt)
AR (1) AR069548A1 (pt)
AT (1) ATE503473T1 (pt)
AU (1) AU2008333263A1 (pt)
BR (1) BRPI0819055A2 (pt)
CA (1) CA2706357C (pt)
CL (1) CL2008003552A1 (pt)
CO (1) CO6280507A2 (pt)
DE (1) DE602008005930D1 (pt)
DK (1) DK2222376T3 (pt)
DO (1) DOP2010000162A (pt)
EA (1) EA016971B1 (pt)
GE (1) GEP20125646B (pt)
HR (1) HRP20110468T1 (pt)
IL (1) IL205962A0 (pt)
MA (1) MA31992B1 (pt)
MX (1) MX2010006257A (pt)
MY (1) MY158799A (pt)
NZ (1) NZ586518A (pt)
PA (1) PA8806001A1 (pt)
PE (1) PE20091209A1 (pt)
PL (1) PL2222376T3 (pt)
PT (1) PT2222376E (pt)
RS (1) RS51785B (pt)
SI (1) SI2222376T1 (pt)
SV (1) SV2010003585A (pt)
TN (1) TN2010000249A1 (pt)
TW (1) TWI391131B (pt)
UA (1) UA100249C2 (pt)
UY (1) UY31499A1 (pt)
WO (1) WO2009071586A2 (pt)
ZA (1) ZA201003640B (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RS55092B1 (sr) * 2011-04-27 2016-12-30 Grindeks Jsc Upotreba 3-karboksi-n-etil-n,n-dimetilpropan-1-aminijum soli u lečenju kardiovaskularne bolesti
RU2457198C1 (ru) * 2011-05-31 2012-07-27 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "Белгородский государственный национальный исследовательский университет" Производное 3-(2,2,2-триметилгидразиний)пропионата - глицинат 3-(2,2,2-триметилгидразиний)пропионат калия, обладающее противоишемической активностью
RU2467748C1 (ru) * 2011-08-08 2012-11-27 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "Белгородский государственный национальный исследовательский университет" Производное 3-(2,2,2-триметилгидразиний)пропионата - глицинат 3-(2,2,2-триметилгидразиний)пропионат калия, обладающее эндотелиопротекторной активностью

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE386014T1 (de) * 2003-08-04 2008-03-15 Grindeks Jsc Meldoniumsalze, verfahren zu deren herstellung und auf ihnen basierende pharmazeutische zusammensetzung
LV13280B (en) * 2003-08-04 2005-11-20 Grindeks Publiska As Sustained release salts of 3-(2,2,2-trimethylhydrazinium)propionate, a method of production and pharmaceutical compositions thereof

Also Published As

Publication number Publication date
CN101951991A (zh) 2011-01-19
ATE503473T1 (de) 2011-04-15
EA201000739A1 (ru) 2011-02-28
ZA201003640B (en) 2011-03-30
SI2222376T1 (sl) 2011-08-31
KR20100084687A (ko) 2010-07-27
DOP2010000162A (es) 2010-08-31
CA2706357C (en) 2013-06-11
NZ586518A (en) 2012-02-24
UA100249C2 (uk) 2012-12-10
IL205962A0 (en) 2010-11-30
EP2222376A2 (en) 2010-09-01
MX2010006257A (es) 2010-08-10
EA016971B1 (ru) 2012-08-30
AR069548A1 (es) 2010-02-03
WO2009071586A3 (en) 2009-09-24
AU2008333263A1 (en) 2009-06-11
PT2222376E (pt) 2011-07-01
CO6280507A2 (es) 2011-05-20
UY31499A1 (es) 2009-01-30
HRP20110468T1 (hr) 2011-08-31
PL2222376T3 (pl) 2011-10-31
GEP20125646B (en) 2012-09-25
PA8806001A1 (es) 2009-08-26
TW200927092A (en) 2009-07-01
DK2222376T3 (da) 2011-07-25
RS51785B (en) 2011-12-31
TWI391131B (zh) 2013-04-01
MA31992B1 (fr) 2011-01-03
PE20091209A1 (es) 2009-09-10
EP2222376B1 (en) 2011-03-30
WO2009071586A2 (en) 2009-06-11
MY158799A (en) 2016-11-15
CA2706357A1 (en) 2009-06-11
DE602008005930D1 (de) 2011-05-12
TN2010000249A1 (en) 2011-11-11
CL2008003552A1 (es) 2009-12-18
US20110028438A1 (en) 2011-02-03
SV2010003585A (es) 2011-03-23
JP2011506285A (ja) 2011-03-03

Similar Documents

Publication Publication Date Title
BRPI0815009A2 (pt) (2s,3r)-n-(2-((3-piridinil)metil)-1-azabiciclo[2.2.2]oct-3-il) benzofuran-2-carboxamida, novas formas de sal, e métodos de uso do mesmo.
BRPI0720124A2 (pt) Composições farmacêuticas e seus métodos de uso.
BRPI0813244A2 (pt) Compostos e seus usos 708
BRPI0814267A2 (pt) Agentes citotóxicos compreendendo novos derivados de tomaicmicina e o seu uso terapêutico.
BRPI0920183A2 (pt) derivados de fenetilamida e seus analogos heterociclicos
BRPI0810696A2 (pt) Composto, composição farmacêutica, e, uso de um composto
BRPI0821027A2 (pt) 4-(4-ciano-2-tioaril) dihidropirimidinonas e seu uso
BRPI0815987A2 (pt) "artigo absorbente"
BRPI0818946A2 (pt) "artigo absorvente"
BRPI0811806A2 (pt) "absorvente higiênico alongado"
BRPI0718182A2 (pt) Oligorribonucleotídeos e seus usos.
DE502007001405D1 (de) Haarpflegezusammensetzung
BRPI0614162A2 (pt) dermocosmético, e, uso de um composto
BRPI0811865A2 (pt) Derivados heterocíclicos pirrolo-nitrogenados, a preparação e o uso farmacêutico dos mesmos
BRPI0717699A2 (pt) "composição e seus processos de preparação, uso de uma composição e uso coméstico de uma composição!
BRPI0813457A2 (pt) Composto de organoenxofre contendo halogênio e uso do mesmo
BRPI0909556A2 (pt) "artigo absorvente de uso pessoal com aba"
BRPI0813263A2 (pt) Oxazolidinonas substituídas e seu uso
BRPI0812701A2 (pt) "artigo absorvente"
DK1901743T3 (da) Quinolinderivater som antibakterielle midler
BRPI0815894A2 (pt) Composição farmacêutica, uso da mesma, e, sais farmaceuticamente aceitáveis de um composto.
DK2007232T3 (da) Papir med slidsbånd
BRPI0817542A2 (pt) NOVOS INIBIDORES DE sEH E SEU USO
BRPI0810019A2 (pt) Composto, composição farmacêutica, e, uso de um composto
BRPI1010764A2 (pt) "sais de derivados de pirazolon-azo biciclo substituído, método de preparação e uso do mesmo"

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.